Medizinische Universitat Wien (MUW)
Thanks to the latest methods in genetics and molecular biology, illness is no longer viewed as a general diagnosis, but as a unique situation in the life of a unique human being. In terms of their individual nature, diagnoses are comparable to fingerprints. A molecular fingerprint allows for precise, tailored prevention and therapy. This is medicine that is as precisely targeted as possible – appropriately referred to as precision medicine. Medicine 4.0 means that the doctors of the 21st century have access to new technology, in particular in post-genomic digital medicine, which is already dramatically changing the professional requirements of researchers and doctors and the skills they need. The strategy defined in the 2024 Roadmap in the Medical University of Vienna Development Plan will meet these challenges. Preparations and planning for the biggest investments in our history, in construction projects at the MedUni Vienna General Hospital Campus to build the innovative centres for precision medicine, translational medicine and technology transfer, as well as the MedUni Campus Mariannengasse preclinical construction project, are in full swing. They are set to provide us with a strong foundation for the future of research, patient care and teaching. A bright future which has been preceded by a successful, but also at times dark past, which as a socially responsible organisation we recognised in the 2018 commemoration year. Together with the University of Vienna, we remembered the events of 80 years previously at an international conference entitled The Anschluss in March 1938: Repercussions for Medicine and Society. This drew attention to the lessons learned from this turning point in the university’s history that must not be forgotten, and the approach we need to take towards it today.